KARIM CHEBLI
Inventor
Stats
- 0 US patents issued
- 3 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 3 US Applications Filed
- 7 Total Citation Count
- Dec 9, 2024 Most Recent Filing
- Jul 17, 2015 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| INSTITUT CURIE | 1
| 2015
|
| UNIVERSITE DE MONTPELLIER | 1
| 2015
|
| ABIVAX | 1
| 2015
|
| CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 1
| 2015
|
Inventor Addresses
| Address | Duration |
|---|---|
| Frontignan, FR | Jul 20, 17 - Mar 27, 25 |
| Frontingnan, FR | Oct 08, 19 - Oct 08, 19 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| C07D: | HETEROCYCLIC COMPOUNDS | 3 |
| C12Q: | MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS | 3 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2025/0100,971 | 2025 | IN VITRO OR EX VIVO METHODS FOR SCREENING A QUINOLINE DERIVATIVE | 0 |
| 2021/0087,145 | 2021 | USE OF QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2 |
| 10435370 | 2019 | Quinoline derivatives for the treatment of inflammatory diseases | 7 |
| 2017/0204,063 | 2017 | QUINOLINE DERIVATIVES FOR THE TREATMENT OF INFLAMMATORY DISEASES | 3 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.